The First Crosslinked Dermal Filler with HA + PN
Prodermis is revolutionising medical aesthetics by combining Hyaluronic Acid (HA) with Polynucleotides (PN) — enhancing hydration, regeneration, and long-lasting volume like never before.
Redefining Aesthetics
Prodermis is revolutionising aesthetic medicine with the world’s first dermal fillers to unite Hyaluronic Acid and Polynucleotides. Alongside advanced boosters and clinical skincare, our portfolio delivers natural, lasting transformation — empowering practitioners to correct, revitalise, and enhance at every stage of treatment.
.webp)
.png)
.png)
Upcoming events
.png)
PRODERMIS AT AMWC Dubai 2025: Launching PROSCULPT™
PRODERMIS is proud to announce the official launch of its brand at the 2025 edition of the Aesthetic & Anti-Aging Medicine World Congress (AMWC) in Dubai, marking an exciting milestone in innovation and excellence within the field of aesthetic medicine.
PRODERMIS at Agorà Congress 2025: Launching PROPROSCULPT™
PRODERMIS is delighted to announce its participation in Agorà Congress 2025. In collaboration with our Italian distributor, we are proud to mark the official launch of PROSCULPT™, an innovative solution in aesthetic medicine designed to redefine standards in sculpting and rejuvenation.
.png)
